Kongressthemen
The First Industry-Dedicated Conference Focused on Accelerating Novel Neuropathic Pain Therapeutics into the Clinic.
The opioid crisis rages on unabated. Meanwhile, the global population continues to age, creating an enormous need for next-generation neuropathic pain treatment and management approaches. This has stimulated a renewed sense of urgency to discover, translate and accelerate non-addictive and clinically effective pain relief therapeutics into the clinic and to patients in pain.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/768538-0?pid=4832
Speakers: Steven Fox, Chairman and Founder, Akelos, Inc, Irving Sucholeiki, President and Chief Executive Officer, Aquilus Pharmaceuticals, Gary J. Bennett, Co-Founder, BioIntervene Inc., and more.
https://go.evvnt.com/768538-2?pid=4832
Herr Customer Service
KategorienAllgemeinmedizin
